Effects of Hilsa ilisa fish oil on the atherogenic lipid profile and glycaemic status of streptozotocin-treated type 1 diabetic rats

Clinical and Experimental Pharmacology and Physiology

Volumn 31, Issue 1-2, 2004, Pages 76-81

  Mahmud, Ishtiaq ^a   Hossain, Anwar ^c   Hossain, Shahdat ^b   Hannan, Abdul ^c   Ali, Liaquat ^c   Hashimoto, Michio ^d  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b JAHANGIRNAGAR UNIVERSITY   (Bangladesh)

^c Bangladesh Institute of Research and Rehabilitation in Diabetes Endocrine and Metabolic Disorders   (Bangladesh)

^d SHIMANE UNIVERSITY   (Japan)

Author keywords

Hilsa ilisa fish oil; Lipid profile; Platelet aggregation; Total anti oxidant status; Type 1 diabetes

Indexed keywords

ANTIOXIDANT; FISH OIL; FRUCTOSAMINE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES CONTROL; DRUG EFFECT; ESTERIFICATION; FATTY ACID BLOOD LEVEL; FEEDING; FISH; GLUCOSE BLOOD LEVEL; HEALTH STATUS; HILSA ILSA; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; NONHUMAN; RAT; THROMBOCYTE AGGREGATION;

ANIMALS; ANTIOXIDANTS; ARTERIOSCLEROSIS; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL, HDL; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FATTY ACIDS; FATTY ACIDS, NONESTERIFIED; FISH OILS; FISHES; FRUCTOSAMINE; INSULIN; LIPIDS; MALE; PLATELET AGGREGATION; RATS; RATS, LONG-EVANS; TRIGLYCERIDES;

EID: 1242337431     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2004.03953.x     Document Type: Article

References (37)

1. Steiner G. Treating lipid abnormalities in patients with type 2 diabetes mellitus. Am. J. Cardiol. 2001; 88: N37-40.
2. Howard BV. Lipoprotein metabolism in diabetes mellitus. J. Lipid Res. 1987; 28: 613-28.
3. Laakso M, Ronnemaa T, Lehto S, Puukka P, Kallio V, Pyorala K. Does NIDDM increase the risk for coronary heart disease similarly in both low and high risk populations? Diabetologia 1995; 38: 487-93.
4. Colwell JA. Multifactorial aspects of the treatment of the type 2 diabetic patient. Metabolism 1997; 46: 1-4.
5. Palumbo PJ. Metfrormin: Effects on cardiovascular risk factors in patients with non-insulin dependent diabetes mellitus. J. Diabetes Complicat. 1998; 12: 110-19.
6. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 1997; 20: 614-20.
7. Elkeles RS, Diamond JR, Poulter C et al. Cardivascular outcomes in type 2 diabetes. A double blind placebo-controlled study of benzafibrate: The St. Mary's Ealing, Northwick Park Diavetes Cardiovascular Disease Prevention (SENDCAP) study. Diabetes Care 1998; 21: 641-8.
8. Garg A, Grundy SM. Nicotinic acid as therapy for dyslipidemia in non-insulin dependent diabetes mellitus. JAMA 1990; 264: 723-6.
9. American Diabetes Association. Position statement: Management of dyslipidemia in adults with diabetes (position statement). Diabetes Care 1998; 21 (Suppl. 1): S36-9.
10. Popp-Snijders C, Schouten JA, Heine RJ, van der Meer J, ven der Veen EA. Dietary supplementation of omega-3 polyunsaturated fatty acids improves insulin sensitivity in non-insulin-dependent diabetes. Diabetes Res. 1987; 4: 141-7.
11. Bang HO, Dyerberg J. Plasma lipids and lipoproteins in Greenlandic west coast Eskimos. Acta Med. Scand. 1972; 192: 85-94.
12. Yamori Y, Nara Y, Iritani N, Workman RJ, Inagami T. Comparision of serum phospholipid fatty acids among fishing and farming Japanese populations and American islanders. J. Nutr. Sci. Vitaminol. 1978; 2: 117-19.
13. Knapp HR, FitzGerald GA. The antihypertensive effects of fish oil. A controlled study of polyunsaturated fatty acids supplements in essential hypertension. N. Engl. J. Med. 1989; 320: 1037-43.
14. Hashimoto M, Hossain MS, Shimada T, Yamazaki H, Fujii Y, Shido O. Effects of docosahexaenoic acid on annular lipid fluidity of the rat bile canalicular plasma membrane. J. Lipid Res. 2001; 42: 1160-8.
15. Sullivan DR, Yue DK, Capogreco C et al. The effects of dietary n-3 fatty acid in animal models of type 1 and type 2 diabetes. Diabetes Res. Clin. Pract. 1990; 9: 225-30.
16. Mayes PA. Metabolism of lipids. In: Harper HA, Rodwell VW, Mayes PA (eds). Reviews of Physiological Chemistry, 16th edn. Lange Publications, Los Altos. 1977; 280-321.
17. Chautan M, Chanussot F, Portugal H, Pauli AM, Lafont H. Effects of salmon oil and corn oil on lipid level and hepato-biliary cholesterol metabolism in rats. Biochim. Biophys. Acta 1990; 1046: 40-5.
18. Wojenski CM, Silver MJ, Walker J. Eicosapentaenoic acid ethyl ester as an antithrombotic agent: Comparison to an extract of fish oil. Biochim. Biophys. Acta 1991; 1081: 33-8.
19. Qazi S, Hossain MS, Mahmu I, Bashar K. Dose effects of pangas (Pangasius pangasius) fish oil and soybean oil on serum and liver lipids in experimental hyppercholesterolemic rats. Dhaka Univ. J. Biol. Sci. 1993; 2: 69-76.
20. Hashimoto M, Shinozuka K, Shahdat HM et al. Antihypertensive effects of all-cis-5,8,11,14,17-icosapentaenoate of aged rats is associated with an increase in the release of ATP from caudal artery. J. Vasc. Res. 1998; 35: 55-62.
21. Hashimoto M, Shinozuka K, Gamoh S et al. The hypotensive effect of docosahexaenoic acid is associated with the enhanced release of ATP from caudal artery of aged rats. J. Nutr. 1999; 129: 70-6.
22. Aviram M, Brook JG. Platelet activation by plasma lipoproteins. Prog. Cardiovasc. Dis. 1987; 30: 61-72.
23. Sinzinger H. Role of platelets in atherosclerosis. Semin. Thromb. Hemost. 1986; 12: 124-33.
24. Winocour PD. Platelets, vascular disease, and diabetes mellitus. Can. J. Physiol. Pharmacol. 1994; 72: 295-303.
25. Hossain MS, Hashimoto M, Hara T, Masumura S. Age-related change in anti-platelet aggregation in feeding of a high fat diet and ω-3 fatty acid in rats. Jpn. J. Pharmacol. 1995; 67: P165 (Abstract).
26. Sanigorski AJ, Sinclair AJ, Hamazaki T. Platelet and aorta arachidonic and eicosapentaenoic acid levels and in vitro eicosanoid production in rats fed high-fat diets. Lipids 1996; 31: 729-35.
27. 2 production. Am. J. Physiol. 1991; 260: H379-85.
28. Morita I, Saito Y, Chang WC, Murota S. Effects of purified eicosapentaenoic acid and arachidonic acid metabolism in cultured murine aortic smooth muscle cells, vessel walls and platelets. Lipids 1983; 18: 42-9.
29. Moncada S, Vane JR. Arachidonic acid metabolites and the interactions between platelets and blood vessel walls. N. Engl. J. Med. 1979; 300: 1142-7.
30. 2+ mobilization of bovine blood platelets. Biochim. Biophys. Acta 1984; 798: 210-15.
31. Hossain S, Hashimoto M, Masumura S. Age-related changes in platelet microviscosity and aggregation in rats. Clin. Exp. Pharmacol. Physiol. 1999; 26: 426-32.
32. Hossain MS, Hashimoto M, Gamoh S, Masumura S. Antioxidative effects of docosahexaenoic acid in the cerebrum versus cerebellum and brain stem of aged hypercholesterolemic rats. J. Neurochem. 1999; 72: 1133-8.
33. Hashimoto M, Hossain MS, Yamasaki H, Yazawa K, Masumura S. Effects of eicosapentaenoic acid and docosahexaenoic acid on plasma membrane fluidity of aortic endothelial cells. Lipids 1999; 34: 1297-304.
34. Balasubramanian S, Simons LA, Chang S, Hickie JB. Reduction in plasma cholesterol and increase in biliary cholesterol by a diet rich in n-3 fatty acids in the rats. J. Lipid Res. 1984; 26: 684-9.
35. Clarke MS, Prendergast Jr MA, Terry AV. Plasma membrane ordering agent Pluronic F-68 (PF-68) reduces neurotransmitter uptake and release and produces learning and memory deficits in rat. Learning Memory 1999; 6: 634-49.
36. Sheridan NP, Block ER. Serotonin transport and fluidity in plsama membrane vesicles: Effect of hyperoxia. Am. J. Physiol. 1988; 254: C781-7.
37. Brownlee M, Vlassara H, Cerami A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann. Intern. Med. 1984; 101: 527-37.